SCHEMBL5312155

SCHEMBL5312155

Cn1cnc2cc(F)ccc2c1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.48
IP6K1 Q92551 1/20 0.46
KDM4E B2RXH2 1/20 0.43
ACVR1 Q04771 2/20 0.43
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
NSD3 Q9BZ95 3/20 0.41
SYK P43405 1/20 0.40
NSD2 O96028 1/20 0.40
MYC P01106 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9919060 0.86 L3MBTL1 (0.59) L3MBTL1IP6K1KDM4EACVR1ALDH1A1
SCHEMBL7600928 0.81 L3MBTL1 (0.49) L3MBTL1IP6K1KDM4EACVR1HDAC3
SCHEMBL30186355 0.79 ESR1 (0.62) L3MBTL1IP6K1KDM4EACVR1SYK
SCHEMBL1500289 0.79 L3MBTL1 (0.48) L3MBTL1IP6K1KDM4EACVR1ALDH1A1
SCHEMBL9919057 0.79 F2RL3 (0.51) L3MBTL1IP6K1KDM4EACVR1ALDH1A1
SCHEMBL12177224 0.79 L3MBTL1 (0.48) L3MBTL1IP6K1KDM4EACVR1SYK
SCHEMBL25111597 0.77 L3MBTL1 (0.46) L3MBTL1IP6K1KDM4EACVR1SYK
SCHEMBL9922440 0.77 KDM4E (0.51) L3MBTL1IP6K1KDM4EACVR1SYK
SCHEMBL9922700 0.77 L3MBTL1 (0.46) L3MBTL1IP6K1KDM4EACVR1SYK
SCHEMBL9922443 0.77 GABRA1 (0.50) L3MBTL1IP6K1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007053352-A2 PYRROLOQUINOLINONE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS WYETH (US) 2007-05-10 WO disclosed
US-20070099911-A1 Pyrroloquinolinone derivatives as 5-hydroxytryptamine-6 ligands WYETH (US) 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099911-A1 Pyrroloquinolinone derivatives as 5-hydroxytryptamine-6 ligands HTR6, HTR5A, HTR2C L3MBTL1 4551/4885IP6K1 699/4885KDM4E 3529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.